AI-Generated Content Disclosure (CA AB 3030) — This article was researched and drafted by Mentis Intelligence, an AI system operated by Carlo P. Honrado M.D., Inc. It is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Its material claims are checked against cited public sources under the governed publishing policy. No physician authorship or individualized clinical judgment is claimed. To speak with a human member of our team, please contact us online or call our office directly.
A-PRF vs L-PRF After Third Molar Extraction
Dr. Carlo Honrado, MD, FACS
Double board-certified facial plastic & reconstructive surgeon · AI-assisted editorial
A-PRF and L-PRF Compared After Impacted Third Molar Extraction
A randomized, double-blind, split-mouth clinical trial reported a comparison of leukocyte- and platelet-rich fibrin and advanced platelet-rich fibrin for bone healing and postoperative outcomes after bilateral impacted third molar extraction, with extraction-socket bone volume assessed by cone-beam computed tomography as the primary bone-healing measure (PubMed).
What did the trial compare?
The study aimed to compare leukocyte- and platelet-rich fibrin and advanced platelet-rich fibrin for bone healing and postoperative outcomes after impacted third molar extraction (PubMed).
L-PRF refers to leukocyte- and platelet-rich fibrin in the study’s comparison of fibrin materials after impacted third molar extraction (PubMed).
A-PRF refers to advanced platelet-rich fibrin in the study’s comparison of fibrin materials after impacted third molar extraction (PubMed).
How was the clinical trial designed?
The study was a randomized, double-blind, split-mouth clinical trial in patients undergoing bilateral impacted third molar extraction (PubMed).
In the trial, one extraction socket received L-PRF and the socket on the opposite side received A-PRF (PubMed).
The study was approved by the Research Ethics Committee of the University of Pernambuco in Recife, Brazil (PubMed).
The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants before inclusion (PubMed).
What outcomes were measured?
The primary outcome was extraction-socket bone volume assessed by cone-beam computed tomography as a measure of bone healing (PubMed).
Secondary outcomes included trabecular thickness, trabecular spacing, soft tissue healing, postoperative pain, and facial swelling (PubMed).
Why are platelet-rich fibrin studies being watched?
The diabetes study was a randomized, split-mouth clinical trial with participant and outcome-assessor blinding at King Abdulaziz University Dental Hospital (PubMed).
Diabetic individuals frequently experience postoperative healing complications characterized by impaired tissue repair and increased susceptibility to infections (PubMed).
Another early, limited study evaluated early clinical and MRI outcomes of arthroscopic microfracture combined with autologous PRF application for osteochondral lesions of the talus (PubMed).
The talus lesion case series included 18 patients aged ≥18 years with Hepple grade III-IV lesions who underwent ankle arthroscopy with microfracture and autologous PRF application (PubMed).
New techniques and devices should be discussed with a qualified physician.
FAQ
What was the main purpose of the third molar trial?
The study aimed to compare leukocyte- and platelet-rich fibrin and advanced platelet-rich fibrin for bone healing and postoperative outcomes after impacted third molar extraction (PubMed).
What does split-mouth mean in this reported trial?
In the trial, one extraction socket received L-PRF and the socket on the opposite side received A-PRF (PubMed).
What was the primary bone-healing measure?
The primary outcome was extraction-socket bone volume assessed by cone-beam computed tomography as a measure of bone healing (PubMed).
What other recovery-related outcomes were included?
Secondary outcomes included trabecular thickness, trabecular spacing, soft tissue healing, postoperative pain, and facial swelling (PubMed).
Was the trial ethically reviewed?
The study was approved by the Research Ethics Committee of the University of Pernambuco in Recife, Brazil (PubMed).
This article was produced by Mentis Intelligence for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual results vary. New techniques and devices should be discussed with a qualified physician. For a consultation with Dr. Carlo Honrado MD, FACS, contact (310) 286-0043 or visit drhonrado.com/contact. Content generated by AI (Mentis Intelligence) per California AB 3030 disclosure requirement.
For consultation information, visit /contact.
Sources
- PubMed: Comparison of bone repair of advanced platelet-rich fibrin (A-PRF) and leukocyte- and platelet-rich fibrin (L-PRF) following the extraction
- PubMed: Early Outcomes of Arthroscopic Microfracture Augmented with Autologous Platelet-Rich Fibrin for Osteochondral Lesions of the Talus.
- PubMed: The Effect of Advanced Platelet-Rich Fibrin on the Healing of Post-Extraction Sockets in Patients with Diabetes: Preliminary Findings from a
Mentis Intelligence
AI SystemGoverned VerificationMentis Intelligence is the AI-powered editorial system of Dr. Carlo Honrado's practice. It researches, drafts, and formats public educational content using governed source and claim verification. Physician review is stated only when a corresponding review record exists.
All content published on drhonrado.com is for educational purposes only and does not constitute medical advice. Please consult Dr. Honrado directly for a personalized evaluation.
Continue reading
Stay Connected
Questions about your care options?
Our team is here to answer your questions and guide you toward the right next step — in a private, unhurried consultation.
Book a Consultation